The industrial analysis of coronary stent in india is projected to grow from USD 0.9 billion in 2025 to USD 1.3 billion by 2035, at a CAGR of 3.5%. Drug-Eluting Stent will dominate with a 52.4% market share, while cobalt chromium will lead the raw material type segment with a 41.7% share.